Literature DB >> 25445233

Clinical decision limits for interpretation of direct bilirubin--a CALIPER study of healthy multiethnic children and case report reviews.

Manjit S Devgun1, Man Khun Chan2, Adil M El-Nujumi3, Rosemary Abara4, David Armbruster5, Khosrow Adeli6.   

Abstract

OBJECTIVE: Measurement of total and direct bilirubin is routinely performed for the differential diagnosis of hyperbilirubinemias. The diagnostic efficiency of a test is dependent on the chosen clinical decision limit. This study is designed to address the clinical decision limits for direct bilirubin. DESIGN AND METHODS: Routine laboratory method was used to measure total and direct bilirubin in children up to the age of 18years. Case study data and serum from a group of healthy children were analyzed and statistical exercise was performed to establish decision limits.
RESULTS: The reference interval for total bilirubin was 1-12μmol/L and for direct bilirubin 1-9μmol/L with the median direct bilirubin of 3μmol/L. In 17% of children with non-pathological jaundice, median total bilirubin was 173μmol/L, median direct bilirubin was 8μmol/L and median direct bilirubin percent was 49%. From birth direct bilirubin percentage decreased until total bilirubin was 41μmol/L, then it remained at ≤10%. Albumin increased with age, and was on average 2.4g/L higher when measured using bromocresol-green compared with bromocresol-purple. An increased amount of direct bilirubin was observed when albumin (detected using the bromocresol-purple method) was >35g/L.
CONCLUSIONS: Direct bilirubin concentration of ≥10μmol/L should be used to consider the presence of conjugated hyperbilirubinemia provided that total bilirubin is also above the reference interval. A high direct bilirubin percentage is unlikely to offer any clinical value when total bilirubin is not increased. It is, however, a useful diagnostic tool when there is a persistence of hyperbilirubinemia or when total bilirubin increases during times of stress with direct bilirubin >10%. Crown
Copyright © 2014. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical decision limit; Conjugated bilirubin; Direct bilirubin; Hyperbilirubinemia; Inherited hyperbilirubinemia; Reference interval

Mesh:

Substances:

Year:  2014        PMID: 25445233     DOI: 10.1016/j.clinbiochem.2014.10.011

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  3 in total

1.  Systemic alterations induced by phospholipase A2 , BmooTX-I, isolated from Bothrops moojeni snake venom.

Authors:  Kellen Cristina Torres Costa; Bruna Barbosa de Sousa; Edigar Henrique Vaz Dias; Déborah Fernanda da Cunha Pereira; Mariana Santos Matias; Wilson Júnior Oliveira; Antônio Vicente Mundim; Carla Cristine Neves Mamede; Luíz Fernando Moreira Izidoro; Júnia de Oliveira Costa; Fábio de Oliveira
Journal:  Int J Exp Pathol       Date:  2018-11-20       Impact factor: 1.925

2.  Opinion Paper: Deriving Harmonised Reference Intervals - Global Activities.

Authors:  Jillian R Tate; Gus Koerbin; Khosrow Adeli
Journal:  EJIFCC       Date:  2016-02-09

3.  Operational impact of using a vanadate oxidase method for direct bilirubin measurements at an academic medical center clinical laboratory.

Authors:  Neha Dhungana; Cory Morris; Matthew D Krasowski
Journal:  Pract Lab Med       Date:  2017-05-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.